NASDAQ · DRIOHealthcareSurgical Instruments

DarioHealth news

$6.62−1.34%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About DarioHealth

DarioHealth Reports First Quarter 2026 Financial and Operating Results
BenzingaMay 13, 6:30 AM ETNeutral

Mixed results with positive operational metrics (sequential revenue growth, 21% expense reduction, improved operating loss) offset by year-over-year revenue decline and continued net losses ($8.2M). Strong strategic positioning with expanded partnerships and AI capabilities, but profitability remains elusive. Stock down 20.5% suggests market skepticism despite operational improvements.

Also mentions DRIO

Articles that tag DRIO but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology